Miyamoto Y - Search Results

1

Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier.

Seymour LW, Miyamoto Y, Maeda H, Brereton M, Strohalm J, Ulbrich K, Duncan R. Seymour LW, et al. Among authors: miyamoto y. Eur J Cancer. 1995;31A(5):766-70. doi: 10.1016/0959-8049(94)00514-6. Eur J Cancer. 1995. PMID: 7640051

2

Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo.

Maeda H, Seymour LW, Miyamoto Y. Maeda H, et al. Among authors: miyamoto y. Bioconjug Chem. 1992 Sep-Oct;3(5):351-62. doi: 10.1021/bc00017a001. Bioconjug Chem. 1992. PMID: 1420435 Review. No abstract available.

3

Augmentation of tumour delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure.

Li CJ, Miyamoto Y, Kojima Y, Maeda H. Li CJ, et al. Among authors: miyamoto y. Br J Cancer. 1993 May;67(5):975-80. doi: 10.1038/bjc.1993.179. Br J Cancer. 1993. PMID: 8494731 Free PMC article.

4

Comparison of the cytotoxic effects of the high- and low-molecular-weight anticancer agents on multidrug-resistant Chinese hamster ovary cells in vitro.

Miyamoto Y, Oda T, Maeda H. Miyamoto Y, et al. Cancer Res. 1990 Mar 1;50(5):1571-5. Cancer Res. 1990. PMID: 2137371

5

Enhancement by verapamil of neocarzinostatin action on multidrug-resistant Chinese hamster ovary cells: possible release of nonprotein chromophore in cells.

Miyamoto Y, Maeda H. Miyamoto Y, et al. Jpn J Cancer Res. 1991 Mar;82(3):351-6. doi: 10.1111/j.1349-7006.1991.tb01853.x. Jpn J Cancer Res. 1991. PMID: 1673676 Free PMC article.

6

Intracavitary administration: pharmacokinetic advantages of macromolecular anticancer agents against peritoneal and pleural carcinomatoses.

Kimura M, Konno T, Miyamoto Y, Kojima Y, Maeda H. Kimura M, et al. Among authors: miyamoto y. Anticancer Res. 1998 Jul-Aug;18(4A):2547-50. Anticancer Res. 1998. PMID: 9703908

7

Enhanced intestinal absorption of a hydrophobic polymer-conjugated protein drug, smancs, in an oily formulation.

Oka K, Miyamoto Y, Matsumura Y, Tanaka S, Oda T, Suzuki F, Maeda H. Oka K, et al. Among authors: miyamoto y. Pharm Res. 1990 Aug;7(8):852-5. doi: 10.1023/a:1015917000556. Pharm Res. 1990. PMID: 2146602

8

S-nitrosylated human alpha(1)-protease inhibitor.

Miyamoto Y, Akaike T, Maeda H. Miyamoto Y, et al. Biochim Biophys Acta. 2000 Mar 7;1477(1-2):90-7. doi: 10.1016/s0167-4838(99)00264-2. Biochim Biophys Acta. 2000. PMID: 10708851 Review.

9

Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour.

Tanaka S, Akaike T, Fang J, Beppu T, Ogawa M, Tamura F, Miyamoto Y, Maeda H. Tanaka S, et al. Among authors: miyamoto y. Br J Cancer. 2003 Mar 24;88(6):902-9. doi: 10.1038/sj.bjc.6600830. Br J Cancer. 2003. PMID: 12644828 Free PMC article.

10

Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity.

Sahoo SK, Sawa T, Fang J, Tanaka S, Miyamoto Y, Akaike T, Maeda H. Sahoo SK, et al. Among authors: miyamoto y. Bioconjug Chem. 2002 Sep-Oct;13(5):1031-8. doi: 10.1021/bc020010k. Bioconjug Chem. 2002. PMID: 12236785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,589 results

Search Page

Filters